MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about TLSA

Recent news which mentions TLSA

< Previous 1 2 3 4 Next >
Don't Get Caught In Equity Rally Hype: Lessons From 2023 To Remember In 2024
Tickers AAPL AMZN FOMO GOOGL
Tags META NVDA artificial intelligence
From Benzinga
Tiziana Expects To Start Enrolling Patients In Its Phase 2 Clinical Trial To Treat Secondary Progressive Multiple Sclerosis (SPMS) Using Its Novel Intranasal Monoclonal Antibody Foralumab
Tickers TLSA
Tags Biotech Benzinga Partner Content
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Tickers AIP ATNF BCEL BSFC
Tags AIP RTO BCEL
From InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Tickers AKAN AKLI BCEL BPTH
Tags CADL Market News TLSA
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Tickers ADN ARAV BCEL BIOC
Tags Today's Market SPRC MBRX
From InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tickers ANEB ASMB BTTX CELC
Tags TLSA Movers Market News
From Benzinga
Tiziana To Announce Six-Month Human Safety And Biomarker Data At The ECTRIMS Annual Congress, Following-Up From Positive Outcomes Data Presented In June
Tickers TLSA
Tags Partner Content Benzinga Biotech
From Benzinga
Tiziana Advances Phase 2 Site Selection For Its Lead Clinical Program In Non-Active Secondary Progressive Multiple Sclerosis (SPMS) And The Company Prepares For Six-Month Clinical Data Update
Tickers RHHBY SNY TLSA
Tags Benzinga RHHBY Biotech
From Benzinga
Tiziana Life Sciences Prepares To Advance Lead Intranasal Foralumab Program In First-Of-Its-Kind Phase 2a Clinical Trial for Non-Active SPMS Patients
Tickers TLSA
Tags Market News Penny Stocks TLSA
From Benzinga
Tesla Cybertruck To Be Used For Oracle's Next-Gen Police Car
Tickers EVS ORCL TECH TLSA
Tags Market News law enforcement TLSA
From Benzinga
Tiziana Reveals Alzheimer's Research Milestone With PNAS Journal After FDA IND Green Light
Tickers TLSA
Tags Market News Penny Stocks TLSA
From Benzinga
Upcoming Phase 2 Data Expected For Longeveron's (NASDAQ: LGVN) Drug For the $4+ Billion Alzheimer's Sector – What To Look For
Tickers ABOS BIIB LGVN TLSA
Tags Market News ABOS Penny Stocks
From Benzinga
Tiziana's Intranasal Foralumab For Alzheimer's Treatment Gets FDA Nod For Phase 2 Trials Under Brigham And Women's Hospital Supervision
Tickers TLSA
Tags General Tiziana Life Sciences News
From Benzinga
Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Tickers AAMC AEY AKTX AREN
Tags IONM DSGN AEY
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tickers BBLG DCTH DSGN GLTO
Tags Benzinga BZI/TFM DSGN
From Benzinga
Nvidia climbs, D.R. Horton gets a Buffett boost, and other stocks on the move
Tickers AMC BK BRK-A BRK-B
Tags CFG BK NVDA
From MarketWatch
Why Tiziana Life Sciences Stock (TLSA) Is Climbing
Tickers TLSA
Tags News Penny Stocks Market News
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Tickers DCTH DSGN EVOK GLTO
Tags GLTO EVOK SCYX
From Benzinga
As Tiziana Life Sciences (NASDAQ: TLSA) Prepares For Phase 2 Trials, Have They Successfully Derisked Foralumab?
Tickers BAYRY SNY TLSA
Tags Tiziana Life Sciences General BAYRY
From Benzinga
Tiziana (NASDAQ: TLSA) Continues The Fight Against Multiple Sclerosis, Will Announce 6-Month Results For Its Novel Treatment Soon
Tickers SNY TLSA
Tags Benzinga Biotech Partner Content
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Tickers ADMP APLM CMPX MDXG
Tags MHUA RSLS Market News
From Benzinga
Publications And Positive Data From Multiple Trials: Six Months In Review For Tiziana Life Sciences (NASDAQ: TLSA)
Tickers SNY TLSA
Tags Benzinga Biotech Partner Content
From Benzinga
Tiziana Life Sciences (NASDAQ: TLSA) Announces Positive Data In Its Secondary-Progressive Multiple Sclerosis Trial, What Could This Mean For The Company?
Tickers PRVB SNY TLSA
Tags Biotech Benzinga Partner Content
From Benzinga
Tiziana's Foralumab Shown To Reduce Microglial Activation In MS Patients; Phase 2a Trial To Begin In Q3 2023
Tickers TLSA
Tags Benzinga Biotech Market News
From Benzinga
Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Tickers AAN ACON AGFY ARWR
Tags CALM SPPI ZEV
From Benzinga
Tiziana Life Sciences To Submit Alzheimer's IND In Q2 2023, Seeks $3 Million From An Alzheimer's Foundation To Support Phase 2a Trial
Tickers TLSA
Tags Benzinga Biotech News
From Benzinga
Tiziana Life Sciences Has Only Fully Human Anti-CD3 mAB In Clinical Studies, Could Be Poised To Improve Care For Patients With Severe Multiple Sclerosis
Tickers EWTX IPHA PRVB SGEN
Tags EWTX Biotech Benzinga
From Benzinga
EXCLUSIVE: Tiziana Life Sciences Plans To Develop Multiple Sclerosis Hopeful For Long COVID Patients
Tickers TLSA
Tags COVID/19 Coronavirus TLSA Health Care
From Benzinga
Treatments For Non-Active Secondary Progressive Multiple Sclerosis Remain Scarce – Tiziana Life Sciences' (NASDAQ: TLSA) First-In-Class Foralumab Is Showing Promise
Tickers PRVB SNY TLSA
Tags Tiziana Life Sciences General SNY
From Benzinga
Tiziana Receives Sign-Off From The FDA To Proceed With Phase 2 Clinical Trial In Patients With Non-Active Secondary Progressive Multiple Sclerosis (SPMS)
Tickers TLSA
Tags Biotech Benzinga TLSA
From Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story